Skip to main content
. 2014 Nov 11;30(2):115–129. doi: 10.1007/s10654-014-9958-4

Table 3.

Pooled relative and absolute effects of HCV testing interventions

Outcome (median length of follow-up) Population (studies) Effect size (95 % CI) I2 Baseline risk per 10,000 population Anticipated absolute effects per 10,000 population (95 % CI) Anticipated absolute effects per 10,000 if HCV prevalence is 10 % Anticipated absolute effects per 10,000 if HCV prevalence is 50 %
Tested for HCV among the eligible population (N/A) 7,435,283 (16 studies) 2.90 (2.01, 4.17) 100 % 59 tests conducteda 112 more HCV antibody tests (from 59 more to 186 more)a N/A N/A
HCV positive cases detected among the eligible population (N/A) 7,424,451 (14 studies) 1.66 (1.27, 2.16) 76 % 2 cases detecteda 1 more case detected (from 0 more to 2 more)a 5 more cases detected (from 2 more to 8 more) 23 more cases detected(from 9 more to 40 more)
Referral to specialist among HCV positive population (6 months) 138 (1 study) 3.01 (1.79, 5.07) N/A 2,000 referrals to specialistb 4,020 more referrals (from 1,580 more to 8,140 more)b 433 more referrals (from 157 to 913 more) 1,298 more referrals (from 470 to 2,739 more)
Attendance at specialist among HCV positive population (6 months) 138 (1 study) 3.66 (1.92, 6.99) N/A 1,385 attending a specialistb 3,683 more attendances (from 1,274 more to 8,294 more)b 287 more attendances (from 94 to 665 more) 1,722 more attendances(from 561 to 3,991 more)
Commenced treatment among HCV positive population (2 years) 683 (4 studies) 3.25 (1.06, 9.95) 0 % 88 commencing treatmentb 197 more commencing (from 53 more to 785 more)b 17 more commencing (from 0 more to 67more) 67 more commencing (from 1 more to 268 more)
SVR among HCV positive population (3 years, 6  months) 515 (2 studies) 1.35 (0.26, 7.09) 0 % 76 achieving an SVRb 27 more achieving SVR (from 56 fewer to 465 more)b 2 more SVRs (from 5 fewer to 43 more) 9 more SVRs (from 21 fewer to 170 more)

Bold type denotes p value < 0.05

N/A not applicable

aPer 10,000 population eligible for testing

bPer 10,000 HCV positive population